Business OpportunityUpdated on 2 November 2025
vitalera: Making Hospital-at-Home a Reality with AI
General Manager at vitalera
Barcelona, Spain
About
vitalera: Transforming Healthcare Through AI and Interoperability
Vitalera is a secure and interoperable AI platform that enables remote patient monitoring and virtual hospital care. Our technology connects seamlessly with existing healthcare systems—simply integrate our API and personalize your care plans to meet the needs of every patient.
By collecting and analyzing real-time health data from multiple sources, Vitalera empowers healthcare providers and researchers to deliver continuous, personalized, and efficient care at home. Our platform transforms fragmented patient data into actionable clinical insights, helping professionals make faster and more informed decisions while improving patient engagement and adherence.
At the heart of Vitalera lies a commitment to precision health—using AI and data intelligence to predict risks, optimize interventions, and support each patient’s unique journey. From chronic disease management to post-discharge monitoring, Vitalera makes healthcare more proactive, connected, and human-centered.
As your trusted partner, we make the concept of “hospital at home” a reality—enhancing outcomes, reducing operational costs, and accelerating clinical research. Through innovation, interoperability, and compassionate design, Vitalera is redefining how healthcare is delivered in the digital age.
Stage
- TRL 8
Topic
- Bioinformatics
- Cardiovascular
- Digestive system
- Diseases of the blood and immune disorders
- External causes of morbidity, mortality
- Physiology
- Injury, poisoning, other external causes
- Mental and behavioural disorders / psychiatry /psychology
- Musculoskeletal system, connective tissue
- Diseases of the nervous system / neurology
- Other symptoms, deviant clinical findings
- Pregnancy, childbirth and the puerperium
- Respiratory
- Pediatrics
- Rare diseases
- Regenerative medicine
Sector
- Health data
- AI
- Oncology
- Rare diseases
Type
- Research collaboration
- Co-development
- Licensing
- Consortium partners
Attached files
Organisation
Similar opportunities
Business Opportunity
DIGITAL HEALTH CARE ASSISTANCE CHRONIC DISEASES
- TRL 7
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Co-development
- Regulatory expert
- Diseases of the ear
- Consortium partners
- External causes of morbidity, mortality
- Endocrine/nutritional/metabolic diseases
- Musculoskeletal system, connective tissue
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Heike Heimann
Company Management WIN5 at WIN5
Stuttgart, Germany
Business Opportunity
- AI
- TRL 6
- TRL 7
- TRL 8
- Other
- ATMPs
- Other
- Genomics
- Oncology
- Physiology
- Pediatrics
- Respiratory
- Health data
- Diagnostics
- Rare diseases
- Rare diseases
- Cardiovascular
- Co-development
- Regulatory expert
- Diseases of the eye
- Clinical validation
- Consortium partners
- Research collaboration
- Neoplasms/cancer/oncology
- Infectious and parasitic diseases
- Endocrine/nutritional/metabolic diseases
- Pregnancy, childbirth and the puerperium
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Pau Gilabert
Health and Innovation Technician at Consorci de Salut i Social de Catalunya
Barcelona, Spain
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- Health data
- Rare diseases
- Research collaboration
- Congenital or chromosomal abnormalities
- Diseases of the blood and immune disorders
Jacques Riviere
Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain